Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-11

Clinical Trial Update: Clinical Trial of Huoluo Pills Combined With Iguratimod Tablets in the Treatment of Rheumatoid Arthritis [NA]

View source ↗

Summary

A clinical trial evaluating Huoluo Pills combined with iguratimod tablets for rheumatoid arthritis is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Huoluo Pills
  • Iguratimod tablets (Iguratimod)

Snippet

Sponsor: Wangjing Hospital, China Academy of Chinese Medical Sciences | Conditions: Rheumatoid Arthritis | NA | Status: NOT_YET_RECRUITING